Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortNarrow-spectrum antibiotic that treats C. difficile colitis.Hospital antibiotic for MRSA and C. difficile.
Body systemAntibioticsAntibiotics
Drug classGut-acting antibioticsGlycopeptides
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesC. difficile infectionMRSA infections, Sepsis with resistant bacteria, Endocarditis, C. difficile colitis (oral), Meningitis (with other drugs)
How it worksKills C. difficile in the gut with little effect on healthy bacteria.Grabs the building blocks of the bacterial wall so they can't link up.
Starts workingWithin days—
Half-lifeAbout 8–10 hours4–6 hours (longer in kidney disease)
Typical adult dose200 mg twice a day for 10 days.IV: weight-based, adjusted to blood levels. C. difficile: 125 mg by mouth four times a day for 10 days.
FormsTabletIV infusion, Capsule, Oral solution
Common side effectsNausea, Vomiting, Constipation, Abdominal painFlushing and itching if infused too fast, Rash, Nausea
Serious side effectsAllergic reactions, Low blood counts (rare)Kidney injury, Hearing damage, Low white cells
Don't take ifAllergy to macrolides (rarely cross-reactive)—
AlcoholUsually no problem in moderation. No direct interaction.—
PregnancyUse with cautionLimited data; avoid unless needed.Use with cautionUsed when needed; levels monitored.
BreastfeedingUse with cautionUnknown amounts in milk.—
In use since—1958
Brand namesUnited States: DificidUnited Kingdom: DificlirIndia: Fidaxomicin (generic)United States: Vancocin, FirvanqUnited Kingdom: Vancocin
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeA07AA12J01XA01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker